J. Michael Kilpatrick

Author

BioCryst Pharmaceuticals (United States)

Also Known As

J M Kilpatrick, J Michael Kilpatrick, J. Kilpatrick, J. M. KILPATRICK, J. M. Kilpatrick, J. Michael Kilpatrick, J.M. Kilpatrick, J.Michael Kilpatrick, JALEH KILPATRICK

Publications

778

Citations

H-Index

Concepts

All Affiliations

BioCryst Pharmaceuticals (United States)University of Alabama at Birmingham Medical University of South Carolina The University of Texas MD Anderson Cancer Center

About

J. Michael Kilpatrick is an author at BioCryst Pharmaceuticals (United States) specializing in medicine, immunology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	504
2	Biochemistry	9	9	343
3	Natural Sciences	6	6	237
4	Allergy	4	4	153
5	Biomolecular Engineering	1	1	42

J. Michael Kilpatrick

Publications

730

Citations

H-Index

Page 1

	Year	Citations
Structure of Human Factor D Sthanam V.L. Narayana, Mike Carson, Ossama El‐Kabbani, Journal of Molecular Biology Human FactorGenetic FactorFactor AnalysisHuman Factor DSystems Biology	1994	83
Opsonic properties of C-reactive protein. Stimulation by phorbol myristate acetate enables human neutrophils to phagocytize C-reactive protein-coated cells. J. Michael Kilpatrick, John E. Volanakis The Journal of Immunology ImmunologyInnate ImmunityCellular PhysiologyInflammationStimulated Pmn	1985	82
Depression of humoral responses and phagocytic functions in vivo and in vitro by fish oil and eicosapentanoic acid Gabriel Virella, J. Michael Kilpatrick, Marı́a Teresa Rugeles, Clinical Immunology and Immunopathology InflammationAnti-inflammatoryOmega-3 Fatty AcidMedicineLipid Peroxidation	1989	68
Structures of native and complexed complement factor D: implications of the atypical his57 conformation and self-inhibitory loop in the regulation of specific serine protease activity Jing Hua, Y. Sudhakara Babu, Dwight Moore, Journal of Molecular Biology Self-inhibitory LoopAtypical His57 ConformationProtein FunctionProtein ExpressionProtein Assembly	1998	65
Demonstration of calcium-induced conformational change(s) in C-reactive protein by using monoclonal antibodies J. Michael Kilpatrick, John F. Kearney, John E. Volanakis Molecular Immunology Immunocytochemical TechniqueSignal TransductionBiochemistryProtein FoldingImmunology	1982	57
Localization of the phosphocholine-binding sites on C-reactive protein by immunoelectron microscopy. Kenneth H. Roux, J. Michael Kilpatrick, John E. Volanakis, The Journal of Immunology Proteinlipid InteractionImmunocytochemical TechniqueImmunologyMolecular BiologyAntigen Processing	1983	49
Nonaffinity Purification of Recombinant gp120 for Use in AIDS Vaccine Development Carl J. Scandella, J. Michael Kilpatrick, WILLIAM D. LIDSTER, AIDS Research and Human Retroviruses Synthetic VirologyImmunologyGlycobiologyMolecular BiologyViral Structural Protein	1993	42
Modelling of the serine-proteinase fold by X-ray and neutron scattering and sedimentation analyses: occurrence of the fold in factor D of the complement system Stephen J. Perkins, Kathryn F. Smith, J. Michael Kilpatrick, Biochemical Journal Protein AssemblySolution ScatteringMolecular BiologyProtein RefoldingProtein Folding	1993	39
Potent orally bioavailable purine nucleoside phosphorylase inhibitor BCX-4208 induces apoptosis in B- and T-lymphocytes—A novel treatment approach for autoimmune diseases, organ transplantation and hematologic malignancies Shanta Bantia, Cynthia Parker, Ramanda Upshaw, International Immunopharmacology Autoimmune DiseaseAllergyApoptosisImmunologyTumor Immunity	2010	36
Structure of 3,4-Dichloroisocoumarin-Inhibited Factor D L. Brent Cole, J. Michael Kilpatrick, N. Chu, Acta Crystallographica Section D Biological Crystallography Pharmaceutical Science3,4-Dichloroisocoumarin-inhibited Factor DChemical BiologyEnzymatic ModificationPharmaceutical Chemistry	1998	25

Page 1